본문으로 건너뛰기
← 뒤로

Mesenteric Castleman disease: Two case reports and review of literature.

1/5 보강
World journal of gastrointestinal surgery 2026 Vol.18(1) p. 114697
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
complete surgical resection of the lesion
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] To our knowledge, this is the first reported case of mesenteric CD transforming into PTCL-NOS, highlighting the complexity and heterogeneity of the clinical course of mesenteric CD. These findings provide insights into the personalized treatment and clinical management of this disease.

Jizhi SN, Chen XY, Wu SS, Chen ZL, Liu AN, Zheng SM

📝 환자 설명용 한 줄

[BACKGROUND] Castleman disease (CD) is a rare lymphoproliferative disorder most commonly occurring in the mediastinum and hilar regions.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Jizhi SN, Chen XY, et al. (2026). Mesenteric Castleman disease: Two case reports and review of literature.. World journal of gastrointestinal surgery, 18(1), 114697. https://doi.org/10.4240/wjgs.v18.i1.114697
MLA Jizhi SN, et al.. "Mesenteric Castleman disease: Two case reports and review of literature.." World journal of gastrointestinal surgery, vol. 18, no. 1, 2026, pp. 114697.
PMID 41695884

Abstract

[BACKGROUND] Castleman disease (CD) is a rare lymphoproliferative disorder most commonly occurring in the mediastinum and hilar regions. Mesenteric involvement is rare, and diagnosis primarily relies on histopathological examination.

[CASE SUMMARY] We report two cases of mesenteric CD with gastrointestinal symptoms accompanied by weight loss. Case 1 underwent complete surgical resection of the lesion. Postoperative pathology confirmed the hyaline vascular type, and the prognosis was favorable. Case 2 also underwent complete surgical resection initially, with postoperative pathology confirming the plasma cell type. However, the disease followed an aggressive course. A second surgery was performed five months later, and postoperative pathology confirmed mesenteric peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). The patient died postoperatively due to acute renal failure.

[CONCLUSION] To our knowledge, this is the first reported case of mesenteric CD transforming into PTCL-NOS, highlighting the complexity and heterogeneity of the clinical course of mesenteric CD. These findings provide insights into the personalized treatment and clinical management of this disease.